Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO StudyRonald Tutrone, Neal D. Shore, Daniel R. Saltzstein et al.|European Urology Oncology|2023Cited by 21
Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal DiseaseWan‐Long Chuang, Alessandra Mangia, Tsung‐Hui Hu et al.|The American Journal of Gastroenterology|2021Cited by 11
THU-144-Ledipasvir/sofosbuvir for 8, 12, or 24 weeks is safe and effective in patients undergoing dialysisWan‐Long Chuang, Alessandra Mangia, Tsung‐Hui Hu et al.|Journal of Hepatology|2019Cited by 7